Open for inclusion

A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion

Cancer type: Multiple diagnosis, Solide tumores

Phase: I/II

Principal Investigator: Guren Tormod

Country: NO

Keywords: Norway, Oslo, solide tumores, Zenocutuzumab, MCLA-128, NRG1 Fusion

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02912949